Londoners with cold symptoms more likely to have Covid, says expert
Professor behind symptom tracker app says Omicron variant causes headaches, sore throat and runny nose
Coronavirus – latest updates
See all our coronavirus coverage
People who have cold symptoms in London are more likely to have Covid, according to the scientist behind the Zoe coronavirus symptom tracker app.
Prof Tim Spector told BBC Radio 4’s Today programme the “majority of symptoms” of the Omicron variant were the same as a common cold, including headaches, sore throat, runny nose, fatigue and sneezing.
Spector urged those with cold symptoms – not just the classic Covid symptoms – to take a test.
“Things like fever, cough and loss of smell are now in the minority of symptoms we are seeing,” he said. “Most people don’t have classic symptoms.
“In London, where Covid is increasing rapidly, it’s far more likely to be Covid than it is to be a cold. We’re seeing doubling in the numbers equivalent to what’s being seen elsewhere, every two-and-a-half days, and that really means numbers are going up.”
Omicron is already the dominant variant in London and will soon account for nearly 100% of infections.
Separately, reacting to data published on Tuesday from South Africa suggesting that high levels of prior infection in the country, rather than the Omicron variant being less severe, may explain relatively low levels of hospitalisation, a government science adviser suggested that panic around the oncoming Omicron wave was unjustified.
Speaking in a personal capacity, Prof Robert Dingwall, a government Covid adviser, from Nottingham Trent University, told the Daily Telegraph: “The Omicron situation seems to be increasingly absurd. There is obviously a lot of snobbery about South African science and medicine but their top people are as good as any you would find in a more universally developed country.
“They clearly don’t feel that the elite panic over here is justified, even allowing for the demographic differences in vulnerability – which are probably more than cancelled by the higher vaccination rate,” he added.
“My gut feeling is that Omicron is very much like the sort of flu pandemic we planned for – a lot of sickness absence from work in a short period, which will create difficulties for public services and economic activity, but not of such a severity as to be a big problem for the NHS and the funeral business.”
A major study looking at 78,000 Omicron cases in South Africa found the risk of hospitalisation was 29% lower compared with the original variant, and 23% lower than Delta, with vaccines holding up well. Fewer people needed intensive care from Omicron, with just 5% of cases admitted to ICU compared with 22% of Delta patients, the study found.
However, Dingwall’s comments were at odds with those of the papers’s authors, who warned that South Africa’s experience of Omicron might not be a reliable indicator for how the Omicron outbreak unfolds in other countries. And the head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, said on Tuesday it would be “wrong for people to consider Omicron as mild”.
Prof Paul Hunter, of the University of East Anglia, said that Dingwall’s comments were “going really out on a limb” and that it was still too early to say how case numbers would translate into hospitalisations in the UK. Hunter said he was optimistic that immunity against severe disease would hold up quite well, but added: “A million cases of Omicron a day would be horrendous even if it was just as bad as flu.”